English, Article edition: Cost Effectiveness of Selective Decontamination of the Digestive Tract in Liver Transplant Patients Petra J. van Enckevort; Jan H. Zwaveling; Jan T. Bottema; ...

User activity

Share to:
 
Bookmark: http://trove.nla.gov.au/version/93677
Physical Description
  • article
Language
  • English

Edition details

Title
  • Cost Effectiveness of Selective Decontamination of the Digestive Tract in Liver Transplant Patients
Author
  • Petra J. van Enckevort
  • Jan H. Zwaveling
  • Jan T. Bottema
  • John K. Maring
  • Ids J. Klompmaker
  • Maarten J.H. Slooff
  • Elisabeth M. Ten Vergert
Physical Description
  • article
Notes
  • Objective: To assess the cost effectiveness of selective decontamination of the digestive tract (SDD) in liver transplant patients. Design: Randomised, placebo-controlled, double-blind trial with an integrated economic evaluation. Setting: Two university hospitals in The Netherlands. Cost effectiveness was assessed from a societal perspective. Patients and participants: 58 patients who underwent liver transplantation and received SDD (n =​ 29) or placebo (n =​ 29) pre- and postoperatively. Interventions: SDD medication and placebo. Main outcome measures: Infection episodes, days of infection, costs of SDD and routine cultures, mean other direct medical costs per patient and additional costs of severe infection. Results: Costs of SDD medicine and routine cultures were on average 3100 US dollars ($US; 1997 values) per patient who underwent SDD. Both preoperatively and postoperatively, costs other than SDD and cultures did not significantly differ between the SDD and the placebo groups (preoperative, $US2370 vs $US2590; postoperative, $US25 455 vs $US24 915). Additional postoperative costs of severe infections were $US250 per day per patient. There were no significant differences in the mean number of infection episodes between groups. Conclusions: SDD leads to the additional costs of SDD medication and routine cultures, whereas no savings in other costs and no improvement in infection episodes are realised. Consequently, SDD may be considered as a nonefficient approach in patients undergoing liver transplantation. The additional costs of severe infection are considerable.
  • Amphotericin B, Colistin, Cost analysis, Liver transplant, Norfloxacin, Pharmacoeconomics, Postoperative infections, Tobramycin
  • RePEc:wkh:phecon:v:19:y:2001:i:5:p:523-530
Language
  • English
Contributed by
OAIster

Get this edition

  • Set up My libraries

    How do I set up "My libraries"?

    In order to set up a list of libraries that you have access to, you must first login or sign up. Then set up a personal list of libraries from your profile page by clicking on your user name at the top right of any screen.

  • All (1)
  • Unknown (1)
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.

User activity


e.g. test cricket, Perth (WA), "Parkes, Henry"

Separate different tags with a comma. To include a comma in your tag, surround the tag with double quotes.

Be the first to add a tag for this edition

Be the first to add this to a list

Comments and reviews

What are comments? Add a comment

No user comments or reviews for this version

Add a comment